We are live on ! Find out more
CBIO

Crescent Biopharma

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$74.4M
BI
2
BVF Inc
California
$49.5M
FFM
3
Fairmount Funds Management
Pennsylvania
$49.5M
VA
4
VR Adviser
New York
$38.4M
LGM
5
Logos Global Management
California
$34.2M +$27.7M +1,417,500 +294%
FIS
6
FCPM III Services
Netherlands
$30.2M
Balyasny Asset Management
7
Balyasny Asset Management
Illinois
$29.9M +$2.98M +152,884 +10%
VPC
8
Vestal Point Capital
New York
$29.3M +$2.54M +130,000 +9%
OM
9
Opaleye Management
Massachusetts
$23.7M +$132K +6,736 +0.5%
BlackRock
10
BlackRock
New York
$22.9M +$22.6M +1,156,037 +999%
TCM
11
Tang Capital Management
California
$20.9M
Vanguard Capital Management
12
Vanguard Capital Management
Pennsylvania
$13.8M -$657K -33,640 -4%
BCM
13
Boxer Capital Management
California
$8.17M
Millennium Management
14
Millennium Management
New York
$7.27M +$1.57M +80,306 +25%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$6.92M +$5.47M +280,355 +269%
Jennison Associates
16
Jennison Associates
New York
$6.81M +$4.4M +225,533 +147%
NCM
17
NEXTBio Capital Management
California
$6.71M
RI
18
RTW Investments
New York
$6.71M
RCP
19
Remedium Capital Partners
Florida
$6.5M
State Street
20
State Street
Massachusetts
$5.68M +$5.4M +276,520 +708%
Ameriprise
21
Ameriprise
Minnesota
$5.45M +$5.91M +302,568 New
Point72 Asset Management
22
Point72 Asset Management
Connecticut
$5.4M
T. Rowe Price Associates
23
T. Rowe Price Associates
Maryland
$4.96M -$546K -27,970 -9%
Marshall Wace
24
Marshall Wace
United Kingdom
$3.86M +$264K +13,520 +7%
PA
25
Perceptive Advisors
New York
$3.72M